<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03291873</url>
  </required_header>
  <id_info>
    <org_study_id>900800700600500400300200100900</org_study_id>
    <nct_id>NCT03291873</nct_id>
  </id_info>
  <brief_title>Topography-Guided Customized PRK Versus Q-value Adjusted PRK in Correction of Myopia With or Without Astigmatism</brief_title>
  <official_title>Topography-Guided Customized PRK (Photorefractive Keratectomy) Versus Q-value Adjusted PRK in Correction of Myopia With or Without Astigmatism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will include patients who will undergo PRK in both eyes, for each patient each eye
      will be randomly allocated to one of 2 procedures:

      topography-guided ablation in one eye (group I) and Q-factor customized ablation in the other
      eye (group II).

      Alcon/Wavelight Light Laser Technolo¬gie (GmbH, Erlangen, Germany) will be used for
      photoablation.

      The wavelight Topolyzer (Wavelight AG, Erlan¬gen, Germany) will be used before and 1, 3 and 6
      months after PRK. Refrac¬tive visual outcomes and corneal aberration changes will be compared
      between the two treatment modalities.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 25, 2017</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in Postoperative spherical equivalent depending on manifest refraction after autorefractometer</measure>
    <time_frame>1 , 3 and 6 months postoperative</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>change in visual acuity using snellen chart</measure>
    <time_frame>1 , 3 and 6 months postoperative</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>change in corneal wavefront aberrations assessed by topolyzer</measure>
    <time_frame>1 , 3 and 6 months postoperative</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>topography guided PRK in one eye</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Topography-guided (placido disk- based) using T-CAT Contoura treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Q-value adjusted ( custom Q) PRK in the other eye</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The target Q will be estimated according to a nomogram considering the patient's age</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PRK</intervention_name>
    <description>PRK using Alcon-Wavelight Excimer Laser EX 500</description>
    <arm_group_label>topography guided PRK in one eye</arm_group_label>
    <arm_group_label>Q-value adjusted ( custom Q) PRK in the other eye</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age more than 18 years

          -  Myopia with up to to -5.00 D with or without astigmatism up to -3.00 D

        Exclusion Criteria:

          -  anterior segment abnormalities (ie, cataracts, corneal scarring)

          -  basement membrane disease

          -  history of recurrent corneal erosions

          -  Schirmer's test less than 5 mm

          -  established or forme fruste keratoconus

          -  macular or retinal disease

          -  current use of immunosuppressive therapy

          -  autoimmune disease

          -  pregnancy, and lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rania E Gad, MSc Ophth</last_name>
    <phone>+201116772703</phone>
    <email>rania_gad_86@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Eyecare centre</name>
      <address>
        <city>Maadi</city>
        <state>Cairo</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rania E Gad, MSc OPhthalmology</last_name>
      <phone>+20 1116772703</phone>
      <email>rania_gad_86@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dar Al Oyun hospital</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rania E Gad, MSC ophthalmology</last_name>
      <phone>+20 1116772703</phone>
      <email>rania_gad_86@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2017</study_first_submitted>
  <study_first_submitted_qc>September 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2017</study_first_posted>
  <last_update_submitted>December 1, 2017</last_update_submitted>
  <last_update_submitted_qc>December 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>Rania Elsayed Gad</investigator_full_name>
    <investigator_title>Assisstant lecturer Faculty of Medicine Helwan University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

